Posts by: Steve Bryson PhD

News

A Phase 2b/3 clinical trial of livoletide, a treatment candidate for excessive eating in people with Prader-Willi syndrome (PWS), has completed recruitment of participants who are 8 to 65 ... Read more

October 10, 2019October 10, 2019

Research Supported by PWS Foundation to Examine Cause of Behavioral Problems, Possible Treatment

News

A grant winner’s research may help to advance a possible treatment of behavioral problems like temper outbursts in Prader-Willi syndrome patients. The treatment, an approved medication but not for ... Read more

September 24, 2019September 24, 2019

Higher Dose of Tesomet Effective in PWS Adolescents, Saniona Reports

News

Saniona announced that adolescents with Prader-Willi syndrome (PWS) showed improvements in weight, body mass index (BMI), and hyperphagia score — measuring appetite reduction — when treated with the investigational therapy ... Read more

August 20, 2019August 20, 2019

Patients Treated With Growth Hormone Score Higher on Vocabulary IQ Tests, Study Shows

News

People with Prader–Willi syndrome (PWS) who received growth hormone therapy had significantly higher vocabulary IQ scores compared with those who did not have the treatment, a study shows. The ... Read more

August 6, 2019August 6, 2019

Millendo Therapeutics Announces Phase 2b/3 Trial Assessing Promising PWS Therapy, Livoletide

News

A potential new treatment for Prader-Willi syndrome (PWS) will be tested in the large, international clinical trial ZEPHYR, in a partnership between Millendo Therapeutics and several research centers, including The ... Read more

Posts by: Steve Bryson PhD

Steve Bryson PhD

Phase 2b/3 Trial of Livoletide Completes Enrollment of PWS Patients Ages 8 to 65

Research Supported by PWS Foundation to Examine Cause of Behavioral Problems, Possible Treatment

Higher Dose of Tesomet Effective in PWS Adolescents, Saniona Reports

Patients Treated With Growth Hormone Score Higher on Vocabulary IQ Tests, Study Shows

Millendo Therapeutics Announces Phase 2b/3 Trial Assessing Promising PWS Therapy, Livoletide

Pin It on Pinterest